Es wird aus natrlichen Inhaltsstoffen hergestellt, ohne Gentechnik, zustzliche Farbstoffe oder knstliche Konservierungsmittel
Wegovy (Semaglutide Injection) Wegovy is the FDA-approved semaglutide medication specifically targeting weight loss
According to the Kotak Institutional Equities report, Intas was a growth leader in November 2025, outperforming the general market
Notably, the report suggested that semaglutide might improve obesity-associated subclinical neurodegeneration and might promote the regeneration of small corneal nerve fibers, indicating a potential neuroprotective effect during treatment
In clinical studies and real-world use, patients frequently report: Nausea Diarrhea Vomiting These symptoms are often most noticeable when starting the medication or increasing the dose
Autophagy in the regulation of tissue differentiation and homeostasis